Surgery Partners Stock Technical Analysis
| SGRY Stock | USD 15.60 0.14 0.91% |
As of the 18th of February 2026, Surgery Partners has the Semi Deviation of 2.42, risk adjusted performance of 0.0116, and Coefficient Of Variation of 16301.87. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Surgery Partners, as well as the relationship between them.
Surgery Partners Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Surgery, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to SurgerySurgery Partners' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Surgery Partners Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 25.45 | Strong Buy | 12 | Odds |
Most Surgery analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Surgery stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Surgery Partners, talking to its executives and customers, or listening to Surgery conference calls.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgery Partners. If investors know Surgery will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Surgery Partners assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (1.36) | Revenue Per Share | Quarterly Revenue Growth 0.066 | Return On Assets | Return On Equity |
Understanding Surgery Partners requires distinguishing between market price and book value, where the latter reflects Surgery's accounting equity. The concept of intrinsic value - what Surgery Partners' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Surgery Partners' price substantially above or below its fundamental value.
Please note, there is a significant difference between Surgery Partners' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgery Partners is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Surgery Partners' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Surgery Partners 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Surgery Partners' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Surgery Partners.
| 11/20/2025 |
| 02/18/2026 |
If you would invest 0.00 in Surgery Partners on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding Surgery Partners or generate 0.0% return on investment in Surgery Partners over 90 days. Surgery Partners is related to or competes with LivaNova PLC, Alphatec Holdings, Brookdale Senior, Scholar Rock, Ardent Health, Ideaya Biosciences, and Heartflow Common. Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary servi... More
Surgery Partners Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Surgery Partners' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Surgery Partners upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.5 | |||
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 9.68 | |||
| Value At Risk | (4.17) | |||
| Potential Upside | 3.68 |
Surgery Partners Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Surgery Partners' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Surgery Partners' standard deviation. In reality, there are many statistical measures that can use Surgery Partners historical prices to predict the future Surgery Partners' volatility.| Risk Adjusted Performance | 0.0116 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.0074 |
Surgery Partners February 18, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0116 | |||
| Market Risk Adjusted Performance | 0.0174 | |||
| Mean Deviation | 1.88 | |||
| Semi Deviation | 2.42 | |||
| Downside Deviation | 2.5 | |||
| Coefficient Of Variation | 16301.87 | |||
| Standard Deviation | 2.45 | |||
| Variance | 6.01 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.0074 | |||
| Maximum Drawdown | 9.68 | |||
| Value At Risk | (4.17) | |||
| Potential Upside | 3.68 | |||
| Downside Variance | 6.25 | |||
| Semi Variance | 5.84 | |||
| Expected Short fall | (1.90) | |||
| Skewness | 0.1816 | |||
| Kurtosis | 0.5906 |
Surgery Partners Backtested Returns
At this stage we consider Surgery Stock to be not too volatile. Surgery Partners owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0254, which indicates the firm had a 0.0254 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Surgery Partners, which you can use to evaluate the volatility of the company. Please validate Surgery Partners' Risk Adjusted Performance of 0.0116, semi deviation of 2.42, and Coefficient Of Variation of 16301.87 to confirm if the risk estimate we provide is consistent with the expected return of 0.063%. Surgery Partners has a performance score of 2 on a scale of 0 to 100. The entity has a beta of 0.68, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Surgery Partners' returns are expected to increase less than the market. However, during the bear market, the loss of holding Surgery Partners is expected to be smaller as well. Surgery Partners right now has a risk of 2.48%. Please validate Surgery Partners total risk alpha, downside variance, as well as the relationship between the Downside Variance and daily balance of power , to decide if Surgery Partners will be following its existing price patterns.
Auto-correlation | 0.59 |
Modest predictability
Surgery Partners has modest predictability. Overlapping area represents the amount of predictability between Surgery Partners time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Surgery Partners price movement. The serial correlation of 0.59 indicates that roughly 59.0% of current Surgery Partners price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.59 | |
| Spearman Rank Test | 0.3 | |
| Residual Average | 0.0 | |
| Price Variance | 0.7 |
Surgery Partners technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Surgery Partners Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Surgery Partners volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Surgery Partners Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Surgery Partners on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Surgery Partners based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Surgery Partners price pattern first instead of the macroeconomic environment surrounding Surgery Partners. By analyzing Surgery Partners's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Surgery Partners's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Surgery Partners specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 0.001516 | 0.00144 | Price To Sales Ratio | 0.99 | 1.47 |
Surgery Partners February 18, 2026 Technical Indicators
Most technical analysis of Surgery help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Surgery from various momentum indicators to cycle indicators. When you analyze Surgery charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0116 | |||
| Market Risk Adjusted Performance | 0.0174 | |||
| Mean Deviation | 1.88 | |||
| Semi Deviation | 2.42 | |||
| Downside Deviation | 2.5 | |||
| Coefficient Of Variation | 16301.87 | |||
| Standard Deviation | 2.45 | |||
| Variance | 6.01 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.0074 | |||
| Maximum Drawdown | 9.68 | |||
| Value At Risk | (4.17) | |||
| Potential Upside | 3.68 | |||
| Downside Variance | 6.25 | |||
| Semi Variance | 5.84 | |||
| Expected Short fall | (1.90) | |||
| Skewness | 0.1816 | |||
| Kurtosis | 0.5906 |
Surgery Partners February 18, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Surgery stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 30,392 | ||
| Daily Balance Of Power | 0.33 | ||
| Rate Of Daily Change | 1.01 | ||
| Day Median Price | 15.59 | ||
| Day Typical Price | 15.59 | ||
| Price Action Indicator | 0.08 |
Additional Tools for Surgery Stock Analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.